Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side Effects
Conclusion: The high therapeutic efficacy, together with the minimal side effects, of this easily synthesized, pre-targeted system exhibited immense potentiality for the clinical application of DOX delivery.
Source: Theranostics - Category: Molecular Biology Authors: Meinan Yao, Xiaotu Ma, Xin Zhang, Linqing Shi, Tianyu Liu, Xiaolong Liang, Huiyun Zhao, Xiaoda Li, Liqiang Li, Hannan Gao, Bing Jia, Fan Wang Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Colorectal Cancer | Heart | Molecular Biology | Toxicology | Vitamin B7